Is Cara Therapeutics Stock a Buy After Its First FDA Drug Approval. There's good news at long last for the beaten-down biotech stock. Keith Speights and Brian Orelli, PhD | Sep 4, 2021 Why Cara ...Feb 16, 2024 · The latest price target for Cara Therapeutics ( NASDAQ: CARA) was reported by Needham on Monday, January 22, 2024. The analyst firm set a price target for 5.00 expecting CARA to rise to within 12 ... Medical - Biomedical and Genetics. $0.032B. $0.042B. Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States. Stock Name. Country. Market Cap. Cara Therapeutics - 53 Year Dividend History | CARA ; Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and ...Coloring games online have become increasingly popular in recent years, and for good reason. Not only do these games provide hours of entertainment, but they also offer a range of ...Cara Therapeutics - 53 Year Dividend History | CARA ; Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and ...5 days ago · Cara Therapeutics (CARA) News Today. $0.57. +0.01 (+1.77%) (As of 02/2/2024 ET) Compare. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability. Source. Sentiment All Sentiments. Source. November 13, 2023 at 1:01 PM · 10 min read. Cara Therapeutics, Inc. – Non-dilutive financing agreement with HealthCare Royalty for up to $40 million expected to extend cash runway into 2025 ...Chris Posner. Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company’s lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with …About the Cara Therapeutics Inc stock forecast. As of 2024 January 30, Tuesday current price of CARA stock is 0.599$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Cara Therapeutics stock price has been showing a declining tendency so we believe that similar market segments were not …Cara Therapeutics Forecast Revenue Growth. Data Unavailable. Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of ...Cara Therapeutics Inc. Item 1(b) - Address of Issuer's Principal Executive Offices: 4 Stamford Plaza, 107 Elm Street, 9th floor Stamford, CT 06902. ... Common Stock. Item 2(e) - CUSIP Number. 140755109. Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1.Cara Therapeutics - 53 Year Dividend History | CARA ; Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and ...Cara Therapeutics, Inc. Common Stock (CARA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...Jul 29, 2019 ... The company plans to use proceeds from the shares' sale — its third major public offering in the past two and a half years — to fund work ...Cara Therapeutics, Inc. Stock price BOERSE MUENCHEN Equities 69C US1407551092 Pharmaceuticals Market Closed - BOERSE MUENCHEN. Other stock markets. 03:43:00 2024-02-02 pm EST 5-day change ...The two main types of listening are discriminative and comprehensive. On top of the two basic types of listening, there are more specific types: informational, critical, therapeuti...Aug 23, 2021 ... Robinhood stock, why sod hood buy now or wait, SESN FDA, pfe stock, Best stocks ... (CARA Therapeutics FDA APPROVED) CARA Stock UPDATE $30pt. 2.5K ...STAMFORD, Conn., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) today announced it will focus its resources on the oral difelikefalin Phase 2/3 clinical program in ...The all-time high Cara Therapeutics stock closing price was 29.19 on April 09, 2021. The Cara Therapeutics 52-week high stock price is 12.49, which is 2053.4% above the current share price. The Cara Therapeutics 52-week low stock price is 0.50, which is 13.8% below the current share price. The average Cara Therapeutics stock price for the last ... Third Quarter 2023 Financial Results. Cash, cash equivalents and marketable securities at September 30, 2023 totaled $83.3 million compared to $156.7 million at December 31, 2022. The decrease in ...The investment bank initiated Cara Therapeutics with a Neutral rating and $16 price target on August 3rd, three weeks before FDA approval. The company ended the first half of 2021 with just over ...In this Motley Fool Live video recorded on Aug. 25, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not Cara stock is a buy after the big news. When our award ...Cara Therapeutics Inc (CARA) stock is down -89.59% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary rankingCara Therapeutics Inc stock is lower by -92.79% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CARA stock a score of 32 out of a possible 100.Medical - Biomedical and Genetics. $0.032B. $0.042B. Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States. Stock Name. Country. Market Cap. According to 4 analyst offering 12-month price targets in the last 3 months, Cara Therapeutics has an average price target of $4.12 with a high of $7.00 and a low …Feb 16, 2024 · Cara Therapeutics Inc (CARA) Stock Falls -3.57% This Week; Should You Buy? InvestorsObserver - Feb 8, 2024, 11:28AM Is it Time to Dump Cara Therapeutics Inc (CARA) Stock After it Is Higher By 1.75 ...CARA has an Altman Z-Score of -9.63 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Cara Therapeutics, Inc. (CARA) stock, including valuation metrics, …Cara Therapeutics Inc (CARA) stock is trading at $0.94 as of 12:49 PM on Tuesday, Nov 28, an increase of $0.01, or 0.92% from the previous closing price of $0.93. The stock has traded between $0.91 and $0.96 so far today. Volume today is less active than usual. So far 114,371 shares have traded compared to average volume of 482,243 …Dec 19, 2023 · According to 4 analyst offering 12-month price targets in the last 3 months, Cara Therapeutics has an average price target of $4.12 with a high of $7.00 and a low of $1.00. The two main types of listening are discriminative and comprehensive. On top of the two basic types of listening, there are more specific types: informational, critical, therapeuti...Approval triggers $1.5 million milestone payment to CaraSTAMFORD, Conn., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company ...Of course Cara Therapeutics may not be the best stock to buy. So you may wish to see this free collection of growth stocks. Please note, the market returns quoted in this article reflect the ...Cara Therapeutics ( NASDAQ: CARA) has an important upcoming PDUFA date, potentially yielding the first approved drug in the company's history, and therefore a new and consistent cash flow. KORSUVA ...View Cara Therapeutics, Inc CARA investment & stock information. Get the latest Cara Therapeutics, Inc CARA detailed stock quotes, stock data, Real-Time …47.45%. Get the latest Cara Therapeutics Inc (CARA) real-time quote, historical performance, charts, and other financial information to help you make more informed …(RTTNews) - Cara Therapeutics, Inc. (CARA) Monday announced it will focus its resources on the oral difelikefalin Phase 2/3 clinical program in notalgia paresthetica (NP) and significantly reduce ...Evofem Biosciences Inc. 0.032. -0.002. -5.8824%. Get Cara Therapeutics Inc (CARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Feb 23, 2022 ... Cara Therapeutics Inc and Vifor (International) Inc; 2021. Accessed December 1, 2021. https://korsuva.com/sites/g/files/brlbcj1286/files ...Cara doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings ...The investment bank initiated Cara Therapeutics with a Neutral rating and $16 price target on August 3rd, three weeks before FDA approval. The company ended the first half of 2021 with just over ...Stock Exchange NASDAQ Ticker Symbol CARA Full Company Profile Financial Performance In 2022, CARA's revenue was $41.87 million, an increase of …3 days ago · 6 equities research analysts have issued 1-year target prices for Cara Therapeutics' shares. Their CARA share price targets range from $2.50 to $25.00. On average, they expect the company's share price to reach $12.79 in the next twelve months. This suggests a possible upside of 1,500.6% from the stock's current price. Feb 5, 2024 · Short interest for Cara Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Cara Therapeutics's stock. Short interest data is updated every two weeks. The all-time high Cara Therapeutics stock closing price was 29.19 on April 09, 2021. The Cara Therapeutics 52-week high stock price is 12.49, which is 2053.4% above the current share price. The Cara Therapeutics 52-week low stock price is 0.50, which is 13.8% below the current share price. The average Cara Therapeutics stock price for the last ... Nov 2, 2023 · Transaction supports progression of late-stage oral difelikefalin clinical programs Non-dilutive capital expected to extend cash runway into 2025 STAMFORD, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE ...Jan 26, 2024 · Get the latest stock quotes, news, and analysis for Cara Therapeutics, Inc. Common Stock (CARA), a biotechnology company developing novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. See the company's key data, financials, market cap, and more. CARA / Cara Therapeutics, Inc. off-exchange short sale volume is shown in the following chart. Short Sale volume shows the number of trades marked as short ...STAMFORD, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of ...About Cara Therapeutics Cara Therapeutics is a close-knit group of scientists, medical experts, and industry leaders deeply committed to the science of changing lives. Our proprietary, novel therapies have the potential to make a significant impact for the millions of pruritus sufferers who have been overlooked.Price Action: Cara Therapeutics has traded as high as $29.64 and as low as $11.22 over a 52-week period. The stock was up 3.5% at $14.78 at last check Tuesday. SHARE THIS POSTCara Therapeutics, Inc. 1 Parrott Drive. Shelton, Connecticut 06484. (203) 567-1501. (Name, address, including zip code, and telephone number, including area ...Dec 18, 2023 · Cara Therapeutics Inc (NASDAQ: CARA) announced the outcome from the dose-finding Part A of the KIND 1 study evaluating the efficacy and safety of oral difelikefalin as adjunct therapy to ... Dec 18, 2023 ... Related Stocks ... Cara Therapeutics Inc (NASDAQ:CARA) announced the outcome from the dose-finding Part A of the KIND 1 study evaluating the ...5 days ago · Cara Therapeutics (CARA) News Today. $0.57. +0.01 (+1.77%) (As of 02/2/2024 ET) Compare. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability. Source. Sentiment All Sentiments. Source. Stock Information Stock Quote NASDAQ: CARA $0.57 Jan 30, 2024 4:00 PM EST Change -0.04 (-6.56%) Volume 455,163 Today's Open $0.60 Previous Close …Cara Therapeutics Inc (CARA) stock is lower by -4.01% while the S&P 500 is down -0.74% as of 12:08 PM on Thursday, Jan 11. CARA is down -$0.02 from the previous closing price of $0.62 on volume of 264,847 shares. Over the past year the S&P 500 is up 19.61% while CARA is down -94.02%. CARA lost -$2.16 per share in the over …Get the latest Cara Therapeutics, Inc. (CARA) stock news and headlines to help you in your trading and investing decisions. Stock Advisor. Our Flagship Service. Return. 611%. S&P Return. 146%. Rule Breakers. High-growth Stocks. Return. 272%. S&P Return. 123%. Returns as of 02/08/2024 ...Cara Therapeutics Inc. CARA (U.S.: Nasdaq) Overview Profile FinancialsSee the latest Cara Therapeutics Inc stock price (CARA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.6 Wall Street analysts have issued twelve-month price objectives for Cara Therapeutics' stock. Their CARA share price targets range from $2.50 to $25.00. On average, they predict the company's share price to reach $12.79 in the next twelve months. This suggests a possible upside of 1,950.0% from the stock's current price.Jan 23, 2024 · Get Cara Therapeutics Inc (CARA.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsCARA THERAPEUTICS INC. CARA THERAPEUTICS INC 0HTC Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company’s lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing …Cara Therapeutics Inc (CARA) stock is trading at $1.22 as of 12:59 PM on Monday, Oct 30, a rise of $0.16, or 14.62% from the previous closing price of $1.06. The stock has traded between $1.09 and $1.23 so far today. Volume today is below average. So far 321,728 shares have traded compared to average volume of 500,124 shares.As we age, it’s important to keep our minds sharp and engaged. One way to do this is by participating in crossword puzzles. Not only are they a fun and enjoyable activity, but they...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...Cara Therapeutics, Inc. Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is ... View the latest Cara Therapeutics Inc. (CARA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Zacks' proprietary data indicates that Cara Therapeutics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the CARA shares ...Dec 19, 2023 · Stay up to date on Cara Therapeutics analyst ratings. If you are interested in following small-cap stock news and performance you can start by tracking it here. Discovering Cara Therapeutics: A ...Cara Therapeutics, Inc. 1 Parrott Drive. Shelton, Connecticut 06484. (203) 567-1501. (Name, address, including zip code, and telephone number, including area ...5 days ago · Cara Therapeutics (CARA) News Today. $0.57. +0.01 (+1.77%) (As of 02/2/2024 ET) Compare. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability. Source. Sentiment All Sentiments. Source. Cara Therapeutics releases figures for Q3 on November 13. Wall Street predict expect Cara Therapeutics will release losses per share of $0.520. Go here to follow Cara Therapeutics stock price in ...Mar 7, 2023 · This is one of them today, Cara Therapeutics. The stock is down after a larger-than-expected miss on estimates, raising concerns on future demand. And the stock is down 26%. As I say, a lot of ... Dec 18, 2023 ... Related Stocks ... Cara Therapeutics Inc (NASDAQ:CARA) announced the outcome from the dose-finding Part A of the KIND 1 study evaluating the ...Dec 25, 2021 · Cara stock has gone in circles without any catalysts to help unlock value, but 2022 is full of growth catalysts. ... Dec. 25, 2021 5:58 AM ET Cara Therapeutics, Inc. (CARA) Stock AMGN 23 Comments ... Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties ...Dec 18, 2023 ... Cara Therapeutics Inc (NASDAQ: CARA) announced the outcome from the dose-finding Part A of the KIND 1 study evaluating the efficacy and safety ...Investors have been pretty optimistic on Cara Therapeutics too, with the stock up 27% to US$1.35 over the past week. It will be interesting to see if today's upgrade is enough to propel the stock ...For the first quarter of 2023, net loss was $26.7 million, or $ (0.49) per basic and diluted share, compared to net loss of $27.7 million, or ( $0.52) per basic and diluted share, for the same period in 2022. Revenues: Total revenue was $6.2 million and $4.8 million for the three months ended March 31, 2023 and 2022, respectively.The 8 analysts with 12-month price forecasts for Cara Therapeutics stock have an average target of 12.44, with a low estimate of 1.00 and a high estimate of 28. …Cara Therapeutics Inc (CARA) stock is lower by -4.01% while the S&P 500 is down -0.74% as of 12:08 PM on Thursday, Jan 11. CARA is down -$0.02 from the previous closing price of $0.62 on volume of 264,847 shares. Over the past year the S&P 500 is up 19.61% while CARA is down -94.02%. CARA lost -$2.16 per share in the over …Feb 7, 2024 · CARA Stock 12 Months Forecast. $5.90. (915.14% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Cara Therapeutics in the last 3 months. The average price target is $5.90 with a high forecast of $11.00 and a low forecast of $1.00. The average price target represents a 915.14% change from the last price of $0.58.Cara Therapeutics Inc. Item 1(b) - Address of Issuer's Principal Executive Offices: 4 Stamford Plaza, 107 Elm Street, 9th floor Stamford, CT 06902. ... Common Stock. Item 2(e) - CUSIP Number. 140755109. Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1.The two main types of listening are discriminative and comprehensive. On top of the two basic types of listening, there are more specific types: informational, critical, therapeuti...2 days ago · According to the issued ratings of 6 analysts in the last year, the consensus rating for Cara Therapeutics stock is Moderate Buy based on the current 1 sell rating, 1 hold rating and 4 buy ratings for CARA. The average twelve-month price prediction for Cara Therapeutics is $12.79 with a high price target of $25.00 and a low price target of $2. ...Aurora Cannabis Inc. $ 0,39. ACB 0,26% ; Cronos Group Inc. $ 2,28. CRON 3,41% ; Tilray Brands Inc. $ 1,84. TLRY 0,81%.Overview. Founded in 2004 with headquarters in Connecticut (84 employees), Cara Therapeutics currently sports an enterprise value of ~$350M and Q2 cash position of $204M providing them operational ...Mar 9, 2021 · The CARA Therapeutics stock forecast for tomorrow is $ 0.609065, which would represent a 2.31% gain compared to the current price. In the next week, the price of CARA is expected to increase by 1.29% and hit $ 0.602960. As far as the long-term CARA Therapeutics stock forecast is concerned, here’s what our predictions are currently …Cara Therapeutics, Inc. (CARA) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 0.6762 +0.0339 (+5.28%) At close: 04:00PM EST. 0.6968 +0.02 (+3.05%) After hours:... If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...The Heat of the Cash Burn. Cara Therapeutics, a beacon of innovation in the biotech landscape, finds itself in a precarious position. Despite sitting on a cash reserve …CARA THERAPEUTICS INC. CARA THERAPEUTICS INC 0HTC Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.Cara Therapeutics ( NASDAQ: CARA) has an important upcoming PDUFA date, potentially yielding the first approved drug in the company's history, and therefore a new and consistent cash flow. KORSUVA ...Feb 16, 2024 · View Cara Therapeutics, Inc CARA investment & stock information. Get the latest Cara Therapeutics, Inc CARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and... 7,177,904. 647,142. 11.091699. Back to CARA Overview. NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid ...About Cara Therapeutics Cara Therapeutics is a close-knit group of scientists, medical experts, and industry leaders deeply committed to the science of changing lives. Our proprietary, novel therapies have the potential to make a significant impact for the millions of pruritus sufferers who have been overlooked.Cara Therapeutics Inc (CARA) stock is trading at $0.92 as of 12:42 PM on Friday, Feb 23, an increase of $0.13, or 15.7% from the previous closing price of $0.80. The stock has traded between $0.82 and $1.13 so far today. Volume today is more active than usual. So far 3,191,325 shares have traded compared to average volume of 574,633 …About the Cara Therapeutics Inc stock forecast. As of 2024 January 30, Tuesday current price of CARA stock is 0.599$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Cara Therapeutics stock price has been showing a declining tendency so we believe that similar market segments were not …Nov 2, 2023 · Transaction supports progression of late-stage oral difelikefalin clinical programs Non-dilutive capital expected to extend cash runway into 2025 STAMFORD, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE ...KORSUVA® is indicated for the treatment of moderate to severe pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis (HD). Approved in the EU, UK and Switzerland with the tradename Kapruvia™. Commercialization rights to difelikefalin in defined indications – Japan: Maruishi Pharmaceutical Co, LTD; South ...Dec 18, 2023 · Cara Therapeutics Inc (NASDAQ: CARA) announced the outcome from the dose-finding Part A of the KIND 1 study evaluating the efficacy and safety of oral difelikefalin as adjunct therapy to ... The investment bank initiated Cara Therapeutics with a Neutral rating and $16 price target on August 3rd, three weeks before FDA approval. The company ended the first half of 2021 with just over ...Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic …CARA Nasdaq Stock Market • NLS real time price • CURRENCY IN USD • Pharmaceuticals. CARA THERAPEUTICS, INC. (CARA) Compare. CARA THERAPEUTICS, ...CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to ... 47.45%. Get the latest Cara Therapeutics Inc (CARA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment... Cara Therapeutics Inc (CARA) stock is trading at $0.92 as of 12:42 PM on Friday, Feb 23, an increase of $0.13, or 15.7% from the previous closing price of $0.80. The stock has traded between $0.82 and $1.13 so far today. Volume today is more active than usual. So far 3,191,325 shares have traded compared to average volume of 574,633 …Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis. Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing. View the latest Cara Therapeutics Inc. (CARA) stock price, news, historical charts, analyst ratings and financial information from WSJ.About Cara Therapeutics Cara Therapeutics is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus.2 days ago · MT. Piper Sandler Downgrades Cara Therapeutics to Neutral From Overweight, Cuts Price Target to $1 From $12. Nov. 14. MT. HC Wainwright Adjusts Price Target on Cara Therapeutics to $7 From $15, Keeps Buy Rating. 23-10-19. MT. HC Wainwright Lowers Price Target on Cara Therapeutics to $15 From $20, Maintains Buy Rating. Cara Therapeutics, Inc. Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is ... Cara Therapeutics (CARA) Institutional Ownership. $0.63. +0.03 (+5.19%) (As of 02/16/2024 04:00 PM ET) Compare. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability. Current.CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to ... 6 days ago · Cara Therapeutics (CARA) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, ... Cara Therapeutics lowest stock price was $0.50 and its highest was $10.83 in the past 12 months. What is Cara Therapeutics’s market cap? Currently, no data Available.Cara Therapeutics Inc’s ( CARA) price is currently down 46.06% so far this month. During the month of March, Cara Therapeutics Inc’s stock price has reached a high of $10.39 and a low of $5.37. Over the last year, Cara Therapeutics Inc has hit prices as high as $13.97 and as low as $5.43. Year to date, Cara Therapeutics Inc’s stock is ...Cara Therapeutics ( NASDAQ: CARA) has an important upcoming PDUFA date, potentially yielding the first approved drug in the company's history, and therefore a new and consistent cash flow. KORSUVA ...You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...Find the latest analyst research for Cara Therapeutics, Inc. Common Stock (CARA) at Nasdaq.com.Jun 30, 2017 · Shares of Cara Therapeutics ( CARA -5.27%), a clinical-stage biotech, dropped by as much as 28.1% in after-hours trading Thursday, and remain more than 25% lower in pre-market trading Friday ... Stock Information Stock Quote NASDAQ: CARA $0.57 Jan 30, 2024 4:00 PM EST Change -0.04 (-6.56%) Volume 455,163 Today's Open $0.60 Previous Close …Institutional Ownership and Shareholders. Cara Therapeutics, Inc. (US:CARA) has 246 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). ….